Gilead Sciences Inc (NYSE:GILD) (fair value) by 2%
| Website | https://www.gilead.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $81,977,393,152 |
| Beta | 0.52052 |
| Average Volume | $8,342,879 |
| Last Dividend | 2.75% |
| Price on Feb 25, 2021 | $65.11 |
| Autochartist™ Valuation | $66.63 |
| Conclusion |
2% (fair value) |
| Download Report |
